Anxiety During the COVID-19 Pandemic: A Web-Based Survey of Thyroid Cancer Survivors

ObjectiveCancer patients and survivors may be disproportionately affected by COVID-19. We sought to determine the effects of the pandemic on thyroid cancer survivors’ health care interactions and quality of life.MethodsAn anonymous survey including questions about COVID-19 and the Patient-Reported Outcomes Measurement Information System profile (PROMIS-29, version 2.0) was hosted on the Thyroid Cancer Survivors’ Association, Inc website. PROMIS scores were compared to previously published data. Factors associated with greater anxiety were evaluated with univariable and multivariable logistic regression.ResultsFrom May 6, 2020, to October 8, 2020, 413 participants consented to take the survey; 378 (92%) met the inclusion criteria: diagnosed with thyroid cancer or noninvasive follicular neoplasm with papillary-like nuclear features, located within the United States, and completed all sections of the survey. The mean age was 53 years, 89% were women, and 74% had papillary thyroid cancer. Most respondents agreed/strongly agreed (83%) that their lives were very different during the COVID-19 pandemic, as were their interactions with doctors (79%). A minority (43%) were satisfied with the information from their doctor regarding COVID-19 changes. Compared to pre-COVID-19, PROMIS scores were higher for anxiety (57.8 vs 56.5; P < .05) and lower for the ability to participate in social activities (46.2 vs 48.1; P < .01), fatigue (55.8 vs 57.9; P < .01), and sleep disturbance (54.7 vs 56.1; P < .01). After adjusting for confounders, higher anxiety was associated with younger age (P < .01) and change in treatment plan (P = .04).ConclusionDuring the COVID-19 pandemic, thyroid cancer survivors reported increased anxiety compared to a pre-COVID cohort. To deliver comprehensive care, providers must better understand patient concerns and improve communication about potential changes to treatment plans.     

Natural occurrence of aflatoxin B<Subscript>1</Subscript> in some Indonesian food and feed products in Yogyakarta in year 1998–1999

A survey was conducted between 1998–1999 to evaluate the level of aflatoxin B₁ (AfB₁) contamination in some selected Indonesian food products, mainly peanuts and peanut products for sale in supermarkets or traditional markets in Yogyakarta, Indonesia. Quantitative analysis was carried out on 118 samples using the ELISA (Enzyme-Linked Immunosorbent Assay) technique. The results indicate that (61.1%) samples were contaminated with AfB₁ at range 2.0 to 249.0 μg/kg. Approximately 50% of the baby food products analysed were contaminated with AfB₁ and the maximum level found was 7.0 μg/kg. In corn products and fermented products, AfB₁ was detected in 66.7 and 50.0% of samples, respectively. A level as high as 5.6 μg/kg of AfB₁ was found in the corn and 6.0 μg/kg in fermented product. AfB₁ was also detected in all rice products, feed products, and other processed products at levels of up to 7.0, 27.0, and 26.0 μg/kg, respectively.     

Facile synthesis of L-malic acid by a consecutive enzymatic reaction

Procedures for a consecutive reaction catalyzed by fumarase and followed by aspartase in ammonium fumarate buffer to facilitate the separation of product have been developed. Fumarate was converted to L-malate in 83%, and the rest of the starting material was converted to aspartate in 16.7% to make a total conversion of 99.7%. After the solvent was evaporated, the malic acid was dissolved in acetone, and the aspartic acid was insoluble. A simple filtration could separate both products.